cdifffoundation.org
Summit Therapeutics PLC Is Granted A “Composition Of Matter” Patent By U.S. Patent and Trademark Office
In The News: C. difficile Infection– Treatment On The Horizon Summit Therapeutics PLC The US patent and trademark office have granted a “composition of matter” patent. It gives a…